Chimin Health Management Co., Ltd.

Shanghai Stock Exchange 603222.SS

Chimin Health Management Co., Ltd. EBIT for the year ending December 31, 2023: USD -3.58 M

Chimin Health Management Co., Ltd. EBIT is USD -3.58 M for the year ending December 31, 2023, a -136.78% change year over year. EBIT means earnings before interest and taxes, it is calculated as operating income plus non-operating income.

Chimin Health Management Co., Ltd. EBIT for the year ending December 31, 2022 was USD 9.74 M, a -70.11% change year over year.
Chimin Health Management Co., Ltd. EBIT for the year ending December 31, 2021 was USD 32.59 M, a 362.71% change year over year.
Chimin Health Management Co., Ltd. EBIT for the year ending December 31, 2020 was USD 7.04 M, a -60.87% change year over year.
Chimin Health Management Co., Ltd. EBIT for the year ending December 31, 2019 was USD 18.00 M, a 82.21% change year over year.

Key data

Date	EBIT	EBITDA	Net Income	EPS (Diluted)

Shanghai Stock Exchange: 603222.SS

Chimin Health Management Co., Ltd.

CEO	Mr. Yunfei Tian
IPO Date	Feb. 17, 2015
Location	China
Headquarters	No. 888, Beiyuan Road
Employees	1,947
Sector	Health Care
Industries Pharmaceuticals Medical Instruments

Description

Chimin Health Management Co., Ltd. develops, produces, and sells human drugs and medical devices in China. The company offers non-PVC soft bag double tube double valves, single valves, and single-tube double valves; plastic bottles; and other packaging forms. It also provides safety syringes, safety injection needles, sterile syringes, irrigators, dispensers, insulin syringes, infusion sets, precision filter infusion sets, and other products; In Vitro diagnosis solutions; and hemodialysis supplies, as well as medical services. The company was formerly known as Zhejiang Chimin Pharmaceutical Co.,Ltd. Chimin Health Management Co., Ltd. was founded in 1996 and is based in Huangyan, China.

Key trends

Past 5 years